H-CYTE (HCYTD)
OTHER OTC:HCYTD
US Market

H-CYTE (HCYTD) Income Statement

0 Followers

H-CYTE Income Statement

Last quarter (Q ), H-CYTE's total revenue was $379.56K, an increase of 0.90% from the same quarter last year. In Q, H-CYTE's net income was $-3.89M. See H-CYTE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.61M$ 1.61M$ 2.15M$ 8.35M$ 818.21K$ 207.34K
Cost of Revenue
$ 592.56K$ 704.71K$ 766.96K$ 2.05M$ 502.79K$ 162.84K
Gross Profit
$ 1.02M$ 906.81K$ 1.38M$ 6.29M$ 315.42K$ 44.51K
Operating Expense
$ 5.60M$ 6.10M$ 8.48M$ 21.34M$ 5.01M$ 6.11M
Operating Income
$ -4.58M$ -5.19M$ -7.09M$ -15.05M$ -4.69M$ -6.06M
Net Non Operating Interest Income Expense
$ -243.40K$ -176.84K$ -1.46M$ -299.33K$ -162.20K$ -395.33K
Other Income Expense
$ -2.46M$ 570.33K$ 2.10M$ -14.46M$ -52.59K$ 957.00
Pretax Income
$ -7.28M$ -4.80M$ -6.46M$ -29.81M$ -4.91M$ -6.46M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -7.28M$ -4.80M$ -6.78M$ -33.20M$ -5.48M$ -6.46M
Basic EPS
$ -34.12$ -30.00$ -0.06$ -0.34$ -0.23$ -0.34
Diluted EPS
$ -34.12$ -30.00$ -0.06$ -0.34$ -0.23$ -0.34
Basic Average Shares
$ 612.38K$ 145.74K$ 111.49M$ 96.37M$ 23.46M$ 19.14M
Diluted Average Shares
$ 612.38K$ 145.74K$ 111.49M$ 96.37M$ 23.46M$ 19.14M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 6.19M$ 6.80M$ 9.24M$ 23.40M$ 5.51M$ 6.27M
Net Income From Continuing And Discontinued Operation
$ -7.28M$ -4.80M$ -6.46M$ -29.81M$ -4.91M$ -6.46M
Normalized Income
$ -7.89M$ -5.41M$ -8.64M$ -15.47M$ -4.86M$ -6.46M
Interest Expense
$ 243.40K$ 176.84K$ 1.46M$ 299.33K$ 162.20K$ 395.33K
EBIT
$ -7.04M$ -4.62M$ -5.00M$ -29.51M$ -4.75M$ -6.06M
EBITDA
$ -7.03M$ -4.61M$ -4.92M$ -28.67M$ -4.72M$ -6.03M
Currency in USD

H-CYTE Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis